France vs Least developed countries: Immunization, HepB3 (% of one-year-old children)
France
96.0%
in 2024
Least developed countries
74.4%
in 2024
France rank
42nd
Least developed countries rank
39th
Immunization, HepB3 (% of one-year-old children) over time
- France
- Least developed countries
How they compare
France currently reports 96.0% against 74.4% in Least developed countries, a difference of 21.6%.
That makes France's figure about 1.3 times Least developed countries's.
The two have swapped places 2 times across 27 shared years of data; in 1998 it was France ahead.
France ranks 42nd and Least developed countries ranks 39th of 188 countries.
France has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | France | Least developed countries | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 25.5% | 0.4% | 25.1% | France |
| 2000s | 36.0% | 35.9% | 0.1% | France |
| 2010s | 83.2% | 76.4% | 6.8% | France |
| 2020s | 95.8% | 74.4% | 21.4% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, France or Least developed countries?
- France, at 96.0% against 74.4% in Least developed countries as of 2024.
- What is the difference in immunization, hepb3 between France and Least developed countries?
- 21.6%, with France ahead.
- How many years of comparable data are there for France and Least developed countries?
- 27 years are reported by both, from 1998 to 2024.
- How do France and Least developed countries rank globally for immunization, hepb3?
- France ranks 42nd and Least developed countries ranks 39th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.